Laboratory Services: Bioanalytical, Biosimilars and Clinical Lab

Laboratory Services: Bioanalytical, Biosimilars and Clinical Lab
Product Description

Lambda provides integrated laboratory services spanning regulated bioanalysis, biosimilar development and central clinical laboratory testing. Capabilities support clinical development through bioanalytical testing, immunogenicity assessment, biomarker analysis and clinical laboratory testing. The central clinical laboratory provides testing across all phases of clinical development, with capabilities covering biomarkers, assay development, safety testing, hematology, cytology, biochemistry, immunology and serology, molecular biology, microbiology and coagulation studies. Pan-India sample logistics and validated laboratory information systems support coordinated laboratory operations. The bioanalytical laboratory supports pharmacokinetic, immunogenicity, pharmacodynamic and biomarker assessments, with capabilities including method development and validation, LC-MS/MS, ELISA, electrochemiluminescence, enzymatic assays and cell-based neutralizing antibody assays.

Lambda Therapeutic Research Ltd

  • Country/Region:
    India
  • Founded:
    1999
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Clinical Research
Contract Research Organisation
Laboratory Services
Nutraceuticals
Regulatory Affairs
Specifications
  • Selling Points
    The bioanalytical infrastructure includes 1,600+ validated assays, 12 high-sensitivity LC-MS/MS platforms, controlled low-temperature storage, capacity for 3M+ samples, 60+ deep freezers, automated sample inventory management and capacity to analyze 110,000+ samples per month. Large-molecule and biosimilar programs are supported by PK, ADA, NAb, PD, biomarker and functional bioanalysis, high-resolution mass spectrometry, cell-based assays, ligand-binding technologies and molecular characterization workflows. 

    The central clinical laboratory includes 25+ validated biomarkers, a validated LIMS and pan-India sample logistics, with testing across hematology, biochemistry, immunology and serology, molecular biology, microbiology, cytology, coagulation and safety testing
  • Supplied from
    Canada; India

Lambda Therapeutic Research Ltd

  • Country/Region:
    India
  • Founded:
    1999
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Clinical Research
Contract Research Organisation
Laboratory Services
Nutraceuticals
Regulatory Affairs

More Products from Lambda Therapeutic Research Ltd (7)

  • Phase I-IV Clinical Trials

    Product Phase I-IV Clinical Trials

    Lambda provides clinical development services spanning Phase I through Phase IV, combining early-phase clinical research with extensive late-phase trial capabilities. 

    Early-phase expertise includes first-in-human, single and multiple ascending dose, biosimilar, drug-drug interaction, food-effe...
  • PK/PD Studies

    Product PK/PD Studies

    Lambda provides comprehensive PK/PD study capabilities across early clinical development, supported by extensive clinical research, bioanalytical, pharmacokinetic and pharmacodynamic expertise. Experience includes first-in-human, single and multiple ascending dose, food-effect, drug-drug interaction, compa...
  • Biologics CDMO

    Product Biologics CDMO

    Lambda’s Biologics CDMO capabilities support biologics and biosimilar programs across the development lifecycle, combining biologics development, analytical sciences and clinical development capabilities. Services span cell line engineering and product development, mammalian cell culture and protein purifi...
  • Large Molecules Regulated Bioanalysis

    Product Large Molecules Regulated Bioanalysis

    Lambda provides regulated bioanalytical support for large molecules, biologics and biosimilars across clinical development. Capabilities include large-molecule PK analysis, anti-drug antibody assessment, neutralizing antibody testing, pharmacodynamic biomarkers, functional bioassays, immunogenicity assessm...
  • Medical Imaging Analysis

    Product Medical Imaging Analysis

    Lambda provides centralized medical imaging services for clinical trials, with capabilities covering image management, centralized image review and reporting, query management and endpoint evaluation. A panel of experienced radiologists supports image assessment across multiple modalities, including OCT, F...
  • Pharmacovigilance

    Product Pharmacovigilance

    Lambda provides end-to-end drug safety and pharmacovigilance support from clinical trials through post-marketing activities. Services include ICSR case processing and electronic submissions, aggregate reports, risk management plans, literature monitoring, signal detection and management, xEVMPD compliance,...
  • Biostatistics and Data Management

    Product Biostatistics and Data Management

    Lambda provides biostatistics and clinical data management capabilities as part of its integrated clinical development model. The function supports clinical programs alongside clinical operations, medical writing, pharmacovigilance, medical imaging, laboratory services, and regulatory affairs. Data managem...

Lambda Therapeutic Research Ltd resources (3)